GSK1379725A is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as a potent inhibitor of specific enzymes that are involved in the growth and proliferation of cancer cells. Researchers employ this compound to investigate its efficacy in halting the progression of various types of cancers, aiming to develop targeted treatments that can minimize damage to healthy cells. Additionally, GSK1379725A is used in preclinical studies to understand its pharmacokinetics and pharmacodynamics, which are crucial for determining its potential as a therapeutic agent. Its role in these studies helps to advance the development of novel anticancer drugs, contributing to the ongoing efforts to improve cancer treatment outcomes.